Shelby Walker

Shelby Walker is an accomplished Chief Legal Officer at Absci, bringing over 20 years of extensive experience in legal and intellectual property matters related to the global development of biologic products for rare diseases. They have held prominent roles, including Senior Vice President of Intellectual Property at CRISPR Therapeutics and Vice President, Associate General Counsel at Dyax. Additionally, Shelby has demonstrated leadership in community initiatives, serving as Chairperson for the Georgetown Special Education Parent Advisory Council. They have pursued advanced education, including multiple degrees in law and biotechnology from prestigious institutions.